These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20937404)

  • 21. Conjugates of ovalbumin and monomethoxypolyethylene glycol abolish late allergic responses and decrease IL-4 and IL-5 mRNA expression in the rat.
    Lavoie JP; Maghni K; Taha R; Yang XX; Lang GM; Sehon AH; Hamid QA; Martin JG
    Pulm Pharmacol Ther; 2003; 16(6):361-9. PubMed ID: 14580928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte function in the airways of allergen-challenged pigs: effects of inhaled and systemic budesonide.
    Fornhem C; Peterson CG; Dahlbäck M; Scheynius A; Alving K
    Clin Exp Allergy; 1996 Dec; 26(12):1436-48. PubMed ID: 9027445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
    Tamm M; Richards DH; Beghé B; Fabbri L
    Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate.
    Delayre-Orthez C; Becker J; Auwerx J; Frossard N; Pons F
    Eur J Pharmacol; 2008 Feb; 581(1-2):177-84. PubMed ID: 18096152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination.
    LaForce C; Weinstein C; Nathan RA; Weinstein SF; Staudinger H; Meltzer EO
    J Asthma; 2011 Aug; 48(6):625-31. PubMed ID: 21726121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
    Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B
    Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary function changes and immunomodulation of Th 2 cytokine expression induced by aminophylline after sensitization and allergen challenge in brown Norway rats.
    Lin CC; Lin CY; Liaw SF; Chen A
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):215-22. PubMed ID: 11868928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation.
    Ohkawara Y; Lei XF; Stämpfli MR; Marshall JS; Xing Z; Jordana M
    Am J Respir Cell Mol Biol; 1997 May; 16(5):510-20. PubMed ID: 9160833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluticasone/formoterol: a new single-aerosol combination therapy for patients with asthma.
    Dissanayake S; Grothe B; Kaiser K
    Respir Med; 2012 Dec; 106 Suppl 1():S20-8. PubMed ID: 23273163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposure of brown Norway rats to diesel exhaust particles prior to ovalbumin (OVA) sensitization elicits IgE adjuvant activity but attenuates OVA-induced airway inflammation.
    Dong CC; Yin XJ; Ma JY; Millecchia L; Barger MW; Roberts JR; Zhang XD; Antonini JM; Ma JK
    Toxicol Sci; 2005 Nov; 88(1):150-60. PubMed ID: 16120749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients.
    Navaratnam P; Friedman HS; Urdaneta E
    Value Health; 2011; 14(2):339-46. PubMed ID: 21402302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diesel exhaust particles on allergic reactions and airway responsiveness in ovalbumin-sensitized brown Norway rats.
    Dong CC; Yin XJ; Ma JY; Millecchia L; Wu ZX; Barger MW; Roberts JR; Antonini JM; Dey RD; Ma JK
    Toxicol Sci; 2005 Nov; 88(1):202-12. PubMed ID: 16107553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
    Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA
    Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of lung hyperresponsiveness, inflammation, and alveolar macrophage mediator production in allergy resistant and susceptible rats.
    Careau E; Sirois J; Bissonnette EY
    Am J Respir Cell Mol Biol; 2002 May; 26(5):579-86. PubMed ID: 11970910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma.
    Price D; Hillyer EV
    Expert Rev Respir Med; 2014 Jun; 8(3):275-91. PubMed ID: 24802285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukotrienes in bile during the early and the late airway responses after allergen challenge of sensitized rats.
    Martin JG; Xu LJ; Toh MY; Olivenstein R; Powell WS
    Am Rev Respir Dis; 1993 Jan; 147(1):104-10. PubMed ID: 8420402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
    Popov TA; Petrova D; Kralimarkova TZ; Ivanov Y; Popova T; Peneva M; Odzhakova T; Ilieva Y; Yakovliev P; Lazarova T; Georgiev O; Hodzhev V; Hodzheva E; Staevska MT; Dimitrov VD
    Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory actions of Chemoattractant Receptor-homologous molecule expressed on Th2 by the antagonist MK-7246 in a novel rat model of Alternaria alternata elicited pulmonary inflammation.
    Gil MA; Caniga M; Woodhouse JD; Eckman J; Lee HH; Salmon M; Naber J; Hamilton VT; Sevilla RS; Bettano K; Klappenbach J; Moy L; Correll CC; Gervais FG; Siliphaivanh P; Zhang W; Zhang-Hoover J; McLeod RL; Cicmil M
    Eur J Pharmacol; 2014 Nov; 743():106-16. PubMed ID: 25261040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD.
    Weinstein C; Staudinger H; Scott I; Amar NJ; LaForce C
    Respir Med; 2011 Jul; 105(7):979-88. PubMed ID: 21398104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler.
    Noonan M; Karpel JP; Bensch GW; Ramsdell JW; Webb DR; Nolop KB; Lutsky BN
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):36-43. PubMed ID: 11206236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.